Short-term low-dose aspirin use prior to immunochemical fecal occult blood testing (iFOBT) significantly increased the test’s sensitivity for detecting advanced colorectal tumors, new study findings ...

Low-dose aspirin may slash colorectal cancer recurrence risk by 55%, according to a recent trial. Image credit: soleg/Getty Images The National Cancer Institute predicts that colorectal cancers will ...

Aspire Biopharma (ASBP) announced that Glatt Air Techniques has undertaken FDA-required testing of the Company’s high-dose sublingual aspirin product. Based on the feasibility study, Aspire has begun ...

Dutch scientists plan to test aspirin against a rare form of cancer after genetic testing suggested the common painkiller might also kill tumor cells. The finding is the latest in a string of studies ...

AURORA, Colo. -- A higher dose of aspirin offered no significant benefit as preeclampsia prevention in high-risk patients, although those with multifetal gestations may have seen some gains, according ...

Aspirin may prolong the lives of men who have been treated for prostate cancer, a recent study suggested. And a clinical trial is under way to test aspirin as an add-on treatment for people with ...